-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on CVS Health, Raises Price Target to $82

Benzinga·05/02/2025 13:39:39
Listen to the news
Barclays analyst Andrew Mok maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $73 to $82.